Stem Cell Oversight Committee
CIHR created the Stem Cell Oversight Committee (SCOC) to review research proposals conducted under the auspices of Agency-eligible institutions, as per the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2) and the Agreement on the Administration of Agency Grants and Awards by Research Institutions.
SCOC reviews for compliance with Chapter 12, Section F, of the TCPS 2, research proposals involving human pluripotent or human totipotent stem cells that have been derived from an embryonic source; and/or will be transferred into humans or non-human animals.
- Terms of Reference
- Stem cell research
- Does the Stem Cell Oversight Committee (SCOC) need to review my research proposal?
- Administrative resources
Members
Mojgan Rastegar, PhD, MSc, BSc, DEA
(Chair)
Professor, Department Biochemistry & Medical Genetics,
Rady Faculty of Health Sciences, University of Manitoba
Scientist, Children’s Hospital Research Institute of Manitoba
Mohamed Abou-el-Enein, MD, PhD, MSPH
Executive Director, USC/CHLA Cell Therapy Program
Associate Professor of Clinical Medicine (Oncology), Pediatrics and Stem Cell Biology & Regenerative Medicine, Keck School of Medicine
University of Southern California
Jessica Esseltine, PhD
Assistant Professor of Cancer and Development, Faculty of Medicine, Division of BioMedical Sciences
Memorial University of Newfoundland
Blake Murdoch, JD, MBA
Research Associate, Health Law Institute
University of Alberta, Faculty of Law
William Pastor, PhD
Assistant Professor, Department of Biochemistry
McGill University
Sophie Petropoulos
Associate Professor at the Karolinska Institutet, Department of Clinical Science, Intervention, and Technology;
Associate Professor at the University of Montreal, Department of Medicine;
Co-director of The Research Center in Reproduction and Fertility in Quebec
Mahmoud Pouladi, PhD
Associate Professor of Medical Genetics, University of British Columbia
Investigator, BC Children’s Research Institute
Karun Singh, PhD
Senior Scientist, Krembil Research Institute, University of Health Network (UHN)
Associate Professor, Faculty of Medicine, University of Toronto
Adjunct Professor, Department of Psychiatry and Behavioral Sciences, McMaster University
Denis Claude Roy, MD, FRCPC
Full professor of medicine, University of Montreal; Chief executive officer, CellCAN and Scientific director of the Centre of Excellence for Cellular Therapy at Montreal’s Maisonneuve-Rosemont Hospital
Amy Wong, PhD
Scientist, Programme in Developmental & Stem Cell Biology, Toronto Hospital for Sick Children
Assistant Professor, Department of Laboratory Medicine & Pathobiology, Temerty Faculty of Medicine, University of Toronto
Dr. Paul Hébert
President, CIHR
Ex-officio, non-voting member
- Date modified: